Design and Synthesis of TRAP1 Selective Inhibitors: H-Bonding with Asn171 Residue in TRAP1 Increases Paralog Selectivity

Sujae Yang, Nam Gu Yoon, Dongyoung Kim, Eunsun Park, So Yeon Kim, Ji Hoon Lee, Changwook Lee, Byoung Heon Kang, Soosung Kang

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Tumor necrosis factor receptor-associated protein 1 (TRAP1) is overexpressed in the mitochondria of various cancer cells, reprograms cellular metabolism to enable cancer cells to adapt to harsh tumor environments. As inactivation of TRAP1 induces massive apoptosis in cancer cells in vitro and in vivo, the development of TRAP1-selective inhibitors has become an attractive approach. A series of purine-8-one and pyrrolo[2,3-d]pyrimidine derivatives was developed based on TRAP1 structure and identified to be highly selective in vitro for TRAP1 over the paralogous enzymes, Hsp90α and Grp94. The TRAP1-selective inhibition strategy via utilization of the Asn171 residue of the ATP-lid was investigated using X-ray crystallography and molecular dynamics simulation studies. Among various synthesized potent TRAP1 inhibitors, 5f possessed a 65-fold selectivity over Hsp90α and a 13-fold selectivity over Grp94. Additionally, 6f had a half-maximal inhibitory concentration (IC50) of 63.5 nM for TRAP1, with a 78-fold and 30-fold selectivity over Hsp90α and Grp94, respectively.

Original languageEnglish
Pages (from-to)1173-1180
Number of pages8
JournalACS Medicinal Chemistry Letters
Volume12
Issue number7
DOIs
StatePublished - 8 Jul 2021

Keywords

  • Cancer
  • HSP90
  • Inhibitor
  • Mitochondria
  • Selectivity
  • TRAP1

Fingerprint

Dive into the research topics of 'Design and Synthesis of TRAP1 Selective Inhibitors: H-Bonding with Asn171 Residue in TRAP1 Increases Paralog Selectivity'. Together they form a unique fingerprint.

Cite this